Trials / Recruiting
RecruitingNCT07402226
Systemic Sclerosis DIet for GastrointESTinal Symptoms
SSc-DIGEST Trial: Systemic Sclerosis DIet for GastrointESTinal Symptoms Randomized Controlled Trial of Low FODMAP, CDED, and NICE Diets for Gastrointestinal Symptoms in Systemic Sclerosis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research will evaluate the effect of diets on bloating/distention, assess changes in abdominal pain, and overall gastrointestinal symptom burden in Systemic Sclerosis. The researchers will do this by comparing outcomes of people assigned to 3 different diets. Following the research specifics of the diets will be available upon contact with the details listed below.
Detailed description
The rationale for keeping the diets (arms/interventions names) vague is it prevents other researchers from using these diets in their studies, minimizes expectation bias of patients (who can have preference for one diet over other) and prevents participants from trying other diets before end of study period in case they don't respond.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Diet 1: Restriction of fermentable carbohydrates | 6 weeks guided diet under the supervision of a dietician restricting fermentable carbohydrates known to trigger GI symptoms. |
| BEHAVIORAL | Diet 2: Elimination of foods harmful to gut barrier and microbiome | 6 weeks guided diet under the supervision of a dietician eliminating of foods harmful to gut barrier and microbiome |
| BEHAVIORAL | Diet 3: Regular meal patterns, soluble fiber, and portion control | 6 weeks guided diet under the supervision of a dietician emphasizing regular meal patterns, soluble fiber, and portion control. |
Timeline
- Start date
- 2026-03-16
- Primary completion
- 2027-04-01
- Completion
- 2027-04-01
- First posted
- 2026-02-11
- Last updated
- 2026-03-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07402226. Inclusion in this directory is not an endorsement.